Reduced antioxidant defense systems in schizophrenia and bipolar I disorder

被引:90
|
作者
Raffa, Monia [2 ]
Barhoumi, Sana [2 ]
Atig, Fatma [2 ]
Fendri, Chiraz [1 ]
Kerkeni, Abdelhamid [2 ]
Mechri, Anwar [1 ,3 ]
机构
[1] Univ Monastir, Fac Med, Res Lab Vulnerabil Psychot Disorders, Monastir 5000, Tunisia
[2] Univ Monastir, Res Lab Trace Elements Free Rad & Antioxidants, Dept Biophys, Fac Med, Monastir 5000, Tunisia
[3] Univ Monastir, Univ Hosp Monastir, Dept Psychiat, Res Lab Vulnerabil Psychot Disorders,Fac Med, Monastir 5000, Tunisia
关键词
Antioxidant enzymes; Bipolar disorder; Glutathione; Oxidative stress; Schizophrenia; SERUM SUPEROXIDE-DISMUTASE; ACID REACTIVE SUBSTANCES; OXIDATIVE STRESS; LIPID-PEROXIDATION; GLUTATHIONE-PEROXIDASE; NITRIC-OXIDE; ENZYME-ACTIVITIES; DIFFERENT FORMS; CORTEX; MALONDIALDEHYDE;
D O I
10.1016/j.pnpbp.2012.07.013
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Numerous evidence and proofs suggest that the oxidative stress contributes to the pathogenesis of schizophrenia (SZ) and bipolar disorder (BD). The aim of this study is to determine the glutathione levels and the antioxidant enzyme activities in blood samples of patients suffering from SZ and patients with bipolar disorder in comparison with the healthy controlled subjects. It was a case-controlled study carried on upon three groups: forty-six SZ patients (41 men and 5 women, mean age = 33.2 +/- 7 years), thirty BD patients (25 men and 5 women, mean age = 31.3 +/- 8 years) and forty healthy controls (33 men and 7 women, mean age = 32.3 +/- 7 years). The glutathione levels are the total glutathione (GSHt), the reduced glutathione (GSHr), and the oxidized glutathione (GSSG) and the antioxidant enzyme activities that are the superoxide dismutase (SOD), the glutathione peroxidase (GPx), and the catalase (CAT) are determined by the spectrophotometer. We noticed that the GSHt and the GSHr levels significantly decreased in both SZ and BD patients in comparison with the healthy control subjects. As for SOD and CAT activities they remained lower for the patients with SZ when compared both with the controls or the BD patients. We noticed as well that the CAT activity was significantly lower in the BD group than that in the control group, whereas, GPx activity showed no significant change in each group. Hence, this report of the decreased plasma levels of GSHt and GSHr, and the impaired antioxidant enzyme activities in SZ and BD patients aims at highlighting the GSH deficit that seems to be contributing to these disorders, and showing that it may be an important indirect biomarker of the oxidative stress for the SZ and BD. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:371 / 375
页数:5
相关论文
共 50 条
  • [41] Asenapine Treatment in Pediatric Patients with Bipolar I Disorder or Schizophrenia: A Review
    Ekaterina Stepanova
    Bradley Grant
    Robert L. Findling
    Pediatric Drugs, 2018, 20 : 121 - 134
  • [42] Asenapine: A Novel Atypical Antipsychotic Agent for Schizophrenia and Bipolar I Disorder
    Timpe, Erin M.
    Chopra, Ritika A.
    JOURNAL OF PHARMACY TECHNOLOGY, 2010, 26 (06) : 352 - 361
  • [43] Mitochondrial Complex I Deficiency in Schizophrenia and Bipolar Disorder and Medication Influence
    Vawter, Marquis
    Rollins, Brandi
    Morgan, Ling
    Hjelm, Brooke
    Sequeira, Adolfo
    Myers, Richard
    Barchas, Jack
    Lee, Francis
    Schatzberg, Alan
    Akil, Huda
    Watson, Stanley
    Bunney, William
    NEUROPSYCHOPHARMACOLOGY, 2017, 42 : S427 - S427
  • [44] Asenapine monotherapy in the acute treatment of both schizophrenia and bipolar I disorder
    Bishara, Delia
    Taylor, David
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2009, 5 : 483 - 490
  • [45] VIOLENCE IN SCHIZOPHRENIA AND BIPOLAR DISORDER
    Volavka, Jan
    PSYCHIATRIA DANUBINA, 2013, 25 (01) : 24 - 33
  • [46] Consanguinity, schizophrenia and bipolar disorder
    Dahdouh-Guermouche, Aicha
    Taleb, Mohammed
    Courtet, Philippe
    Semaoune, Boualem
    Malafosse, Alain
    ANNALES MEDICO-PSYCHOLOGIQUES, 2013, 171 (04): : 246 - 250
  • [47] Neurobiology of schizophrenia and bipolar disorder
    Hans-Jórgen Mφller
    Annals of General Psychiatry, 7 (Suppl 1)
  • [48] Pareidolia in Schizophrenia and Bipolar Disorder
    Abo Hamza, Eid G.
    Keri, Szabolcs
    Csigo, Katalin
    Bedewy, Dalia
    Moustafa, Ahmed A.
    FRONTIERS IN PSYCHIATRY, 2021, 12
  • [49] VIRUSES, SCHIZOPHRENIA, AND BIPOLAR DISORDER
    YOLKEN, RH
    TORREY, EF
    CLINICAL MICROBIOLOGY REVIEWS, 1995, 8 (01) : 131 - 145
  • [50] Is there a schizophrenia/bipolar disorder border?
    Tohen, M.
    BIPOLAR DISORDERS, 2015, 17 : 10 - 10